A Phase I/II Trial of Combination of PKC412 and 5-azacytidine (AZA) for the Treatment of Patients with Refractory or Relapsed (R/R) Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Nazha, Aziz, Kantarjian, Hagop, Borthakur, Gautam, Kadia, Tapan, Faderl, Stefan, Ravandi, Farhad, Estrov, Zeev, Jabbour, Elias, Quintas-Cardama, Alfonso, Cortes, JorgeVolume:
13
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2013.07.078
Date:
September, 2013
File:
PDF, 76 KB
english, 2013